Successful Completion pf phase 3 trial marks another discovery for the company and ready to bring the cardiovascular drug to another level.
Todays price @ 50.55
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
